CSL040
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CSL040, covering 2026-02-03 to 2026-02-03. Get the full timeline:
Most recent: Clinical Trial Update: First-In-Human Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Escalating Single And Multiple Doses Of CSL040 In Healthy Subjects [Phase 1]